CMI
MED icon

Clare Market Investments’s Medifast MED Stock Holding History

Clare Market Investments’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,610
Closed -$337K – 180
2021
Q4 		$337K Buy
+1,610
New +$333K 0.09% 103

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Clare Market Investments's MED Position: Q1 2022 in Review

Clare Market Investments sold out of Medifast (MED) in Q1 2022, closing a stake of 1,610 shares — an estimated $337K sold.

Clare Market Investments first reported a position in MED in Q4 2021 and held it in 1 quarter. The position peaked at $337K in Q4 2021. 288 funds tracked by Wall St. Rank hold MED as of Q1 2022.

  • Clare Market Investments reported no remaining Medifast position as of Q1 2022 after selling out during the quarter.
  • Clare Market Investments sold 1,610 Medifast shares in Q1 2022, an estimated $337K.
  • Clare Market Investments first reported a position in Medifast in Q4 2021 and held it in 1 quarter.
  • Clare Market Investments's Medifast position peaked at $337K in Q4 2021.
  • 288 funds tracked by Wall St. Rank held Medifast as of Q1 2022.

Based on Clare Market Investments's 13F filing for Q1 2022, filed 20 Feb 2025.